These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 26962561)
1. Contrast enhanced ultrasonography in assessing the treatment response to transarterial chemoembolization in patients with hepatocellular carcinoma. Sparchez Z; Mocan T; Radu P; Anton O; Bolog N Med Ultrason; 2016 Mar; 18(1):96-102. PubMed ID: 26962561 [TBL] [Abstract][Full Text] [Related]
2. Imaging of intrahepatic progression of hepatocellular carcinoma post transarterial chemoembolization. A long-term, prospective evaluation of contrast-enhanced ultrasonography (CEUS). Moschouris H; Kalokairinou-Motogna M; Vrakas S; Papadatou A; Karagiannis E; Kiltenis M; Kladis-Kalentzis K; Marmaridou K; Papadogeorgopoulos N; Malagari K Med Ultrason; 2017 Apr; 19(2):134-142. PubMed ID: 28440346 [TBL] [Abstract][Full Text] [Related]
3. The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study. Cho YZ; Park SY; Choi EH; Baik SK; Kwon SO; Kim YJ; Cha SH; Kim MY Clin Mol Hepatol; 2015 Jun; 21(2):165-74. PubMed ID: 26157754 [TBL] [Abstract][Full Text] [Related]
4. Utility of Contrast-Enhanced Ultrasound for Early Therapeutic Evaluation of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization. Watanabe Y; Ogawa M; Kumagawa M; Hirayama M; Miura T; Matsumoto N; Nakagawara H; Yamamoto T; Moriyama M J Ultrasound Med; 2020 Mar; 39(3):431-440. PubMed ID: 31436341 [TBL] [Abstract][Full Text] [Related]
5. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report. Kaufmann S; Schulze M; Spira D; Horger M Acta Radiol; 2016 Jan; 57(1):8-12. PubMed ID: 25585848 [TBL] [Abstract][Full Text] [Related]
6. Transarterial Chemoembolization of HCC with Radiopaque Microspheres: Evaluation with Computed Tomography and the Complementary Role of Contrast-Enhanced Ultrasonography. Moschouris H; Malagari K; Dimakis A; Kiakidis T; Anagnostopoulou A Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1075-1083. PubMed ID: 32394087 [TBL] [Abstract][Full Text] [Related]
7. Intra-arterial contrast-enhanced ultrasound (IA CEUS) for localization of hepatocellular carcinoma (HCC) supply during transarterial chemoembolization (TACE): a case series. Lekht I; Nayyar M; Luu B; Guichet PL; Ho J; Ter-Oganesyan R; Katz M; Gulati M Abdom Radiol (NY); 2017 May; 42(5):1400-1407. PubMed ID: 28008454 [TBL] [Abstract][Full Text] [Related]
8. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results. Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486 [TBL] [Abstract][Full Text] [Related]
9. Contrast-Enhanced Ultrasonography Versus Contrast-Enhanced Computed Tomography for Assessment of Residual Tumor From Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: A Meta-analysis. Zhong J; Su Z; Zhang Y; Zhang H; Lin P; Tang X; Zheng R J Ultrasound Med; 2018 Aug; 37(8):1881-1890. PubMed ID: 29380404 [TBL] [Abstract][Full Text] [Related]
10. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma. Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188 [TBL] [Abstract][Full Text] [Related]
11. Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma. Park KH; Kwon SH; Lee YS; Jeong SW; Jang JY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Kim YJ Clin Mol Hepatol; 2015 Jun; 21(2):158-64. PubMed ID: 26157753 [TBL] [Abstract][Full Text] [Related]
12. Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST. Liu M; Lin MX; Lu MD; Xu ZF; Zheng KG; Wang W; Kuang M; Zhuang WQ; Xie XY Eur Radiol; 2015 Aug; 25(8):2502-11. PubMed ID: 25702094 [TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced ultrasonography of hepatocellular carcinoma after chemoembolisation using drug-eluting beads: a pilot study focused on sustained tumor necrosis. Moschouris H; Malagari K; Papadaki MG; Kornezos I; Matsaidonis D Cardiovasc Intervent Radiol; 2010 Oct; 33(5):1022-7. PubMed ID: 20101403 [TBL] [Abstract][Full Text] [Related]
14. Assessment of Transarterial Chemoembolization Using Super-resolution Ultrasound Imaging and a Rat Model of Hepatocellular Carcinoma. Brown KG; Li J; Margolis R; Trinh B; Eisenbrey JR; Hoyt K Ultrasound Med Biol; 2023 May; 49(5):1318-1326. PubMed ID: 36868958 [TBL] [Abstract][Full Text] [Related]
15. Early evaluation of treatment response to transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The role of dynamic three-dimensional contrast-enhanced ultrasound. Cao J; Dong Y; Fan P; Mao F; Chen K; Chen R; Huang B; Cheng Y; Wang WP Clin Hemorheol Microcirc; 2021; 78(4):365-377. PubMed ID: 33682701 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: Comparison of contrast-enhanced ultrasound with multiphase computed tomography. Paul SB; Dhamija E; Gamanagatti SR; Sreenivas V; Yadav DP; Jain S; Shalimar ; Acharya SK Diagn Interv Imaging; 2017 Mar; 98(3):253-260. PubMed ID: 27692674 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of treatment response after chemoembolisation (TACE) in hepatocellular carcinoma using real time image fusion of contrast-enhanced ultrasound (CEUS) and computed tomography (CT)--preliminary results. Wobser H; Wiest R; Salzberger B; Wohlgemuth WA; Stroszczynski C; Jung EM Clin Hemorheol Microcirc; 2014; 57(2):191-201. PubMed ID: 24577382 [TBL] [Abstract][Full Text] [Related]
18. Dynamic evaluation and quantification of microvascularization during degradable starch microspheres transarterial Chemoembolisation (DSM-TACE) of HCC lesions using contrast enhanced ultrasound (CEUS): a feasibility study. Wiggermann P; Wohlgemuth WA; Heibl M; Vasilj A; Loss M; Schreyer AG; Stroszczynski C; Jung EM Clin Hemorheol Microcirc; 2013; 53(4):337-48. PubMed ID: 22555335 [TBL] [Abstract][Full Text] [Related]
19. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors. Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679 [TBL] [Abstract][Full Text] [Related]
20. mRECIST criteria and contrast-enhanced US for the assessment of the response of hepatocellular carcinoma to transarterial chemoembolization. Moschouris H; Malagari K; Papadaki MG; Kornezos I; Stamatiou K; Anagnostopoulos A; Chatzimichael K; Kelekis N Diagn Interv Radiol; 2014; 20(2):136-42. PubMed ID: 24317334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]